ZYVERSA THERAPEUTICS INC

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 98987D300 since 12/18/2024, newest first.

Filer	% of Class	Shares	Form	Filed
Armistice Capital, LLC 13G/A Amendment 1	4.99%	416,800	13G/A Amendment 1	8/14/2025 Event 6/30/2025
Armistice Capital, LLC	4.99%	416,800
Steven Boyd	4.99%	416,800
Armistice Capital, LLC 13G	10.0%	285,037	13G	5/15/2025 Event 3/31/2025
Armistice Capital, LLC	10.0%	285,037
Steven Boyd	10.0%	285,037

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2025 Q3	1	7.00	$1.00	$0
2025 Q2	7	66.1 k	$44.7 k	$0
2025 Q1	8	69.9 k	$43.9 k	$0
2024 Q4	9	81.1 k	$86.2 k	$0
2024 Q3	8	3.06 k	$7.22 k	$0
2024 Q2	6	10.3 k	$38.8 k	$0